Your browser doesn't support javascript.
loading
Robot-Assisted Magnetic Resonance Imaging-Targeted versus Systematic Prostate Biopsy; Systematic Review and Meta-Analysis.
Petov, Vladislav; Azilgareeva, Camilla; Shpikina, Anastasia; Morozov, Andrey; Krupinov, German; Kozlov, Vasiliy; Singla, Nirmish; Gómez Rivas, Juan; Jesús, Moreno-Sierra; Puliatti, Stefano; Checcucci, Enrico; Rodler, Severin; Belenchon, Ines Rivero; Kowalewski, Karl-Friedrich; Veccia, Alessandro; Mcfarland, Jonathan; Cacciamani, Giovanni E; Taratkin, Mark; Enikeev, Dmitry.
Afiliación
  • Petov V; Institute for Urology and Reproductive Health, Sechenov University, 119991 Moscow, Russia.
  • Azilgareeva C; Institute for Urology and Reproductive Health, Sechenov University, 119991 Moscow, Russia.
  • Shpikina A; Institute for Urology and Reproductive Health, Sechenov University, 119991 Moscow, Russia.
  • Morozov A; Institute for Urology and Reproductive Health, Sechenov University, 119991 Moscow, Russia.
  • Krupinov G; Institute for Urology and Reproductive Health, Sechenov University, 119991 Moscow, Russia.
  • Kozlov V; Department of Public Health and Healthcare, Sechenov University, 119991 Moscow, Russia.
  • Singla N; Departments of Urology and Oncology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Gómez Rivas J; Department of Urology, Clinico San Carlos University Hospital, 28040 Madrid, Spain.
  • Jesús MS; Young Academic Urologists (YAU) Working Group in Urotechnology of the European Association of Urology, 30016 Arnhem, The Netherlands.
  • Puliatti S; Department of Urology, Clinico San Carlos University Hospital, 28040 Madrid, Spain.
  • Checcucci E; Young Academic Urologists (YAU) Working Group in Urotechnology of the European Association of Urology, 30016 Arnhem, The Netherlands.
  • Rodler S; Urology Department, University of Modena and Reggio Emilia, 42121 Modena, Italy.
  • Belenchon IR; Young Academic Urologists (YAU) Working Group in Urotechnology of the European Association of Urology, 30016 Arnhem, The Netherlands.
  • Kowalewski KF; Department of Surgery, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, 10060 Turin, Italy.
  • Veccia A; Young Academic Urologists (YAU) Working Group in Urotechnology of the European Association of Urology, 30016 Arnhem, The Netherlands.
  • Mcfarland J; Department of Urology, Klinikum der Universität München, 81377 Munich, Germany.
  • Cacciamani GE; Young Academic Urologists (YAU) Working Group in Urotechnology of the European Association of Urology, 30016 Arnhem, The Netherlands.
  • Taratkin M; Department of Uro-Nephrology, Virgen del Rocío University Hospital, 41013 Seville, Spain.
  • Enikeev D; Young Academic Urologists (YAU) Working Group in Urotechnology of the European Association of Urology, 30016 Arnhem, The Netherlands.
Cancers (Basel) ; 15(4)2023 Feb 13.
Article en En | MEDLINE | ID: mdl-36831524
INTRODUCTION: Robot-assisted devices have been recently developed for use in prostate biopsy. However, it is possible advantages over standard biopsy remain unclear. We aimed to assess the diagnostic performance and safety of robot-assisted targeted (RA-TB) and systematic prostate biopsies (RA-SB). METHODS: A systematic literature search was performed in MEDLINE and Scopus databases. The detailed search strategy is available at Prospero (CRD42021269290). The primary outcome was the clinically significant prostate cancer (PCa) detection rate. The secondary outcomes included the overall detection rate of PCa, cancer detection rate per core, and complications. RESULTS: The clinically significant cancer detection rate, overall cancer detection rate, and "per patient" did not significantly differ between RA-TB and RA-SB [OR = 1.02 (95% CI 0.83; 1.26), p = 0.05, I2 = 62% and OR = 0.95 (95% CI 0.78; 1.17), p = 0.17, I2 = 40%, respectively]. There were no differences in the clinically insignificant cancer detection rate "per patient" between RA-TB and RA-SB [OR = 0.81 (95% CI 0.54; 1.21), p = 0.31, I2 = 0%]. RA-TB had a significantly higher cancer detection rate "per core" [OR = 3.01 (95% CI 2.77; 3.27), p < 0.0001, I2 = 96%]. CONCLUSION: RA-TB and RA-SB are both technically feasible and have comparable clinical significance and overall PCa detection rates.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Suiza